azimilide has been researched along with Torsade de Pointes in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wolbrette, DL | 1 |
| Al-Khalidi, HR; Brum, JM; Camm, AJ; Holroyde, MJ; Karam, R; Pratt, CM; Schwartz, PJ; Sonnenblick, EH; Spyt, MJ | 1 |
| Brendorp, B; Elming, H; Køber, L; Pedersen, OD; Pehrson, S; Torp-Petersen, C | 1 |
| Carlsson, L; Kowey, PR; Liu, T; Wu, Y; Yan, GX | 1 |
| Connolly, S; Kerr, C; Kowey, P; Page, RL; Pritchett, EL; Wilkinson, WE | 1 |
| Al-Khalidi, HR; Borggrefe, M; Brum, JM; Camm, AJ; Dorian, P; Holroyde, MJ; Marcello, SR; Pratt, CM; Schwartz, PJ | 1 |
| Grant, AO; Tranquillo, J | 1 |
| Kaźmierczak, J; Peregud-Pogorzelska, M; Rzeuski, R | 1 |
| Clemett, D; Markham, A | 1 |
| Leunissen, JD; Van Opstal, JM; Vos, MA; Wellens, HJ | 1 |
| Connolly, SJ; Marcello, SR; Page, RL; Pritchett, EL; Schnell, DJ; Wilkinson, WE | 1 |
2 review(s) available for azimilide and Torsade de Pointes
| Article | Year |
|---|---|
Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Conduction System; Humans; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Risk Assessment; Risk Factors; Sex Factors; Sotalol; Sulfonamides; Tachycardia; Torsades de Pointes | 2003 |
A benefit-risk assessment of class III antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Combined Modality Therapy; Defibrillators, Implantable; Dronedarone; Heart Conduction System; Humans; Hydantoins; Imidazolidines; Ion Transport; Life Tables; Membrane Potentials; Meta-Analysis as Topic; Phenethylamines; Piperazines; Risk Assessment; Sotalol; Sulfonamides; Survival Analysis; Torsades de Pointes; Treatment Outcome | 2004 |
3 trial(s) available for azimilide and Torsade de Pointes
| Article | Year |
|---|---|
Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Double-Blind Method; Female; Heart Rate; Humans; Hydantoins; Imidazoles; Imidazolidines; Life Tables; Male; Middle Aged; Myocardial Infarction; Neutropenia; Piperazines; Potassium Channel Blockers; Risk Factors; Survival Analysis; Torsades de Pointes; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Female; Heart Rate; Humans; Hydantoins; Imidazolidines; Long QT Syndrome; Male; Middle Aged; Piperazines; Syncope; Torsades de Pointes; Treatment Outcome | 2006 |
Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Double-Blind Method; Electrocardiography; Female; Humans; Hydantoins; Imidazoles; Imidazolidines; Male; Middle Aged; Patient Selection; Piperazines; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Telemetry; Torsades de Pointes | 2002 |
6 other study(ies) available for azimilide and Torsade de Pointes
| Article | Year |
|---|---|
Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Hydantoins; Imidazolidines; Male; Phenethylamines; Piperazines; Rabbits; Sulfonamides; Torsades de Pointes | 2005 |
Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Databases, Factual; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Hydantoins; Imidazolidines; Male; Middle Aged; Piperazines; Time Factors; Torsades de Pointes | 2006 |
Action potential and QT prolongation not sufficient to cause Torsade de Pointes: role of action potential triangulation.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium Channels, L-Type; Guinea Pigs; Hydantoins; Imidazolidines; Myocytes, Cardiac; Nicardipine; Patch-Clamp Techniques; Phenethylamines; Piperazines; Rabbits; Sulfonamides; Torsades de Pointes | 2007 |
QT Interval prolongation and torsades de pointes due to a coadministration of ciprofloxacin and azimilide in a patient with implantable cardioverter-defibrillator.
Topics: Aged; Anti-Arrhythmia Agents; Anti-Infective Agents; Ciprofloxacin; Defibrillators, Implantable; Drug Interactions; Electrocardiography; Female; Humans; Hydantoins; Imidazolidines; Long QT Syndrome; Piperazines; Tachycardia, Ventricular; Torsades de Pointes | 2007 |
Azimilide.
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Headache; Humans; Hydantoins; Imidazoles; Imidazolidines; Piperazines; Recurrence; Torsades de Pointes | 2000 |
Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dogs; Heart Block; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sulfonamides; Torsades de Pointes; Ventricular Function | 2001 |